These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 10405359
1. Influence of the human high-affinity IgG receptor FcgammaRI (CD64) on residual infectivity of neutralized dengue virus. Schlesinger JJ, Chapman SE. Virology; 1999 Jul 20; 260(1):84-8. PubMed ID: 10405359 [Abstract] [Full Text] [Related]
2. Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32). Rodrigo WW, Jin X, Blackley SD, Rose RC, Schlesinger JJ. J Virol; 2006 Oct 20; 80(20):10128-38. PubMed ID: 17005690 [Abstract] [Full Text] [Related]
4. Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection. Moi ML, Lim CK, Takasaki T, Kurane I. J Gen Virol; 2010 Jan 20; 91(Pt 1):103-11. PubMed ID: 19776239 [Abstract] [Full Text] [Related]
5. Functional characteristics of the high affinity IgG receptor, FcγRI. van der Poel CE, Spaapen RM, van de Winkel JG, Leusen JH. J Immunol; 2011 Mar 01; 186(5):2699-704. PubMed ID: 21325219 [Abstract] [Full Text] [Related]
7. Gain-of-function mutations in FcgammaRI of NOD mice: implications for the evolution of the Ig superfamily. Gavin AL, Tan PS, Hogarth PM. EMBO J; 1998 Jul 15; 17(14):3850-7. PubMed ID: 9670002 [Abstract] [Full Text] [Related]
8. C-reactive protein specifically binds to Fcgamma receptor type I on a macrophage-like cell line. Tron K, Manolov DE, Röcker C, Kächele M, Torzewski J, Nienhaus GU. Eur J Immunol; 2008 May 15; 38(5):1414-22. PubMed ID: 18412163 [Abstract] [Full Text] [Related]
9. High affinity IgG binding by FcgammaRI (CD64) is modulated by two distinct IgSF domains and the transmembrane domain of the receptor. Harrison PT, Allen JM. Protein Eng; 1998 Mar 15; 11(3):225-32. PubMed ID: 9613847 [Abstract] [Full Text] [Related]
10. Antibody-enhanced binding of dengue-2 virus to human platelets. Wang S, He R, Patarapotikul J, Innis BL, Anderson R. Virology; 1995 Oct 20; 213(1):254-7. PubMed ID: 7483271 [Abstract] [Full Text] [Related]
11. Characterization of an FcgammaRI-binding peptide selected by phage display. Berntzen G, Brekke OH, Mousavi SA, Andersen JT, Michaelsen TE, Berg T, Sandlie I, Lauvrak V. Protein Eng Des Sel; 2006 Mar 20; 19(3):121-8. PubMed ID: 16423844 [Abstract] [Full Text] [Related]
12. The many faces of FcγRI: implications for therapeutic antibody function. Swisher JF, Feldman GM. Immunol Rev; 2015 Nov 20; 268(1):160-74. PubMed ID: 26497519 [Abstract] [Full Text] [Related]
13. Single Nucleotide Polymorphisms of the High Affinity IgG Receptor FcγRI Reduce Immune Complex Binding and Downstream Effector Functions. Brandsma AM, Ten Broeke T, van Dueren den Hollander E, Caniels TG, Kardol-Hoefnagel T, Kuball J, Leusen JHW. J Immunol; 2017 Oct 01; 199(7):2432-2439. PubMed ID: 28814603 [Abstract] [Full Text] [Related]
14. A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. Brown MG, King CA, Sherren C, Marshall JS, Anderson R. J Leukoc Biol; 2006 Dec 01; 80(6):1242-50. PubMed ID: 16940332 [Abstract] [Full Text] [Related]
15. Canine mast cell activation via human IgG1 and IgG4. Sato Y, Teshima R, Nakamura R, Takagi K, Sasaki N, Sawada J, Kitani S. Int Arch Allergy Immunol; 2004 Oct 01; 135(2):154-60. PubMed ID: 15345915 [Abstract] [Full Text] [Related]
16. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli. Jaiswal S, Khanna N, Swaminathan S. Protein Expr Purif; 2004 Jan 01; 33(1):80-91. PubMed ID: 14680965 [Abstract] [Full Text] [Related]
17. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. Kou Z, Quinn M, Chen H, Rodrigo WW, Rose RC, Schlesinger JJ, Jin X. J Med Virol; 2008 Jan 01; 80(1):134-46. PubMed ID: 18041019 [Abstract] [Full Text] [Related]
18. Depletion of synovial macrophages in rheumatoid arthritis by an anti-FcgammaRI-calicheamicin immunoconjugate. van Roon JA, Bijlsma JW, van de Winkel JG, Lafeber FP. Ann Rheum Dis; 2005 Jun 01; 64(6):865-70. PubMed ID: 15539412 [Abstract] [Full Text] [Related]
19. Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgammaRI (CD64) and fcalphaRI (CD89). van Egmond M, van Spriel AB, Vermeulen H, Huls G, van Garderen E, van de Winkel JG. Cancer Res; 2001 May 15; 61(10):4055-60. PubMed ID: 11358825 [Abstract] [Full Text] [Related]
20. Structural mechanism of high affinity FcγRI recognition of immunoglobulin G. Lu J, Sun PD. Immunol Rev; 2015 Nov 15; 268(1):192-200. PubMed ID: 26497521 [Abstract] [Full Text] [Related] Page: [Next] [New Search]